This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharmaceutical Compliance Congress (PCC) 2027

PCC 2027 STARTS IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
April 27-29, 2027
Gaylord National Resort & Convention Center | Oxon Hill, MDWe Will See You in 2027!
Menu
Key Sessions
Lisa LeCointe-Cephas
Chairperson's Opening Remarks
Johnson & Johnson Innovative Medicine
Kiley Smith Kelly
FIRESIDE KEYNOTE When a Culture of Compliance Becomes a Competitive Advantage
Ernst & Young LLP
keyboard_arrow_right

2026 Day 2 Agenda - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
close
2026 Day 2 Agenda - ET (Eastern Time, GMT-05:00)
close
Showing 1 of 1 Streams
11:20am - 12:20pm
Interpreting the Latest DOJ Actions and Priorities
  • Commentary on the latest developments from DOJ
  • Update on DOJ’s health care fraud, FCPA, and other corporate enforcement
  • DOJ guidance to prosecutors and its significance for pharmaceutical companies
  • The current state of False Claims Act litigation
  • Angela Rodin - Principal, Global Ethics, KPMG
  • Amanda Masselam Strachan - Partner, Wilmer Hale
  • Diane Seol - Of Counsel, Choate
  • Laura Akowuah - Special Counsel, Cooley
  • Paula Ramer - Partner, Arnold and Porter
Topic Intensives - Delve into the detail with practical scenarios and hands on approaches
Showing 1 of 1 Streams
3:55pm - 4:50pm
Guardrails for Evolving Field Facing Roles
  • How can we ensure we are communicating in every way we can communicate whilst remaining compliant?
  • Interactions with GPOs – examining the types of interactions with field roles, what they can talk about and what can they do
  • Medical commercial interactions: helping Compliance keep pace with agile approaches
  • Considerations when using scientific platforms to engage HCPs
  • Kimberly Gregorio - Vice President, Commercial Excellence and Client Engagement, P360
  • Peter Agnoletto - Ethics and Business Integrity Global Head for aT1D&CVM Franchise and US General Medicines Strategic Advisor, Sanofi
  • Catherine Shimsky - Vice President, ERC Advisory, Policy and Learning, Novartis
  • Noah Goldstein - Counsel, Life Sciences Legal, Regulatory and Compliance, Porzio Bromberg & Newman, P.C.
2026 Day 1 Agenda
Next2026 Day 3 Agenda
Filter
Streams
Formats
Choose Day